NCT05317000: 5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
- State
- Under way
- Phase
- Phase 2
- People
- 50 planned
- Started
- 23 Mar 2023
- Primary completion
- 30 Jun 2028
- Arms
- Arm C: Combination 5-azacytidine and Nivolumab
- Results
- None posted
- 7 Apr 2022: Trial registered
- 23 Mar 2023: Trial started